Quantcast
Last updated on April 17, 2014 at 9:20 EDT

Latest Compression fracture Stories

2012-10-15 11:27:13

SANTA ROSA, Calif., Oct. 15, 2012 /PRNewswire/ -- Osseon Therapeutics, Inc. is gearing up for growth as European sales now account for over 40% of sales since new product introductions in Europe. Osseon's newest product, the Osseoflex(®) SB, represents the first technological advance in vertebral augmentation devices in years. The Osseoflex SB steerable bone tamp, introduced to the European marketplace in Q2 2012, has driven the company's revenue. Distribution has expanded to 6...

2012-09-11 02:28:51

SANTA ROSA, Calif., Sept. 11, 2012 /PRNewswire/ -- Osseon announces the release of Osseoflex(®) SN+ (steerable needle) for the treatment of vertebral compression fractures (VCF). Osseoflex SN+ is the latest addition to Osseon's family of vertebral augmentation medical devices. Osseoflex SN+ is steerable and can be used for either bipedicular or unipedicular access, cavity creation, and vertebral augmentation within the vertebral body. Osseoflex SN+ shares all of the features and benefits...

2012-08-27 02:24:35

DALLAS, August 27, 2012 /PRNewswire/ -- The new market research report "Spine Surgery Devices Market Forecasts to 2017 - Global Trends & Competitive Analysis" published by MarketsandMarkets ( http://www.marketsandmarkets.com), - analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World. Browse 173 tables and 26 figures/charts spread across 409 pages and in-depth TOC of "Spine Surgery...

2012-08-07 02:29:49

INDIANAPOLIS, Aug. 7, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced data from a Phase III trial comparing the effects of FORTEO(®) (teriparatide [rDNA origin] injection) and risedronate on back pain in postmenopausal women with osteoporotic vertebral fractures. The study showed no difference between FORTEO and risedronate on the primary endpoint of at least a 30 percent reduction in worst back pain from baseline to six months of therapy, as assessed by a numeric...

2012-07-31 02:27:47

SANTA CLARA, Calif., July 31, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced it has met the pre-determined stopping rules for enrollment completion in the KAST (Kiva System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) clinical trial. (Logo: http://photos.prnewswire.com/prnh/20110418/SF84532LOGO) The KAST trial enrolled 300 patients and is being conducted to support a subsequent 510(k) filing...

2012-06-28 02:28:05

SANTA CLARA, Calif., June 28, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced it completed a $25 million Series D round of financing. The spine company intends to use the proceeds to sustain global commercialization of its three breakthrough minimally invasive products to treat degenerative disc disease (DDD) with spinal fusion and vertebral compression fractures (VCFs), as well as for additional initiatives to...

2012-05-24 20:42:46

New IOF report forecasts dramatic rise in osteoporosis-related fractures due to aging of Brazilian population, with costly economic and social repercussions A new Audit report on fragility fractures, issued today by the International Osteoporosis Foundation (IOF),  predicts that Brazil will experience an explosion in the number of fragility fractures due to osteoporosis in the coming decades. Osteoporosis, a disease which weakens bones and makes them more likely to fracture, is...

2012-05-24 20:37:42

New IOF Audit compiles epidemiological data and quantifies burden; warns of impending explosion in number of fractures as ageing population surges The International Osteoporosis Foundation (IOF), in cooperation with medical and patient societies from throughout Latin America, has today published a landmark report which compiles osteoporosis-related data on 14 countries and the region as a whole. The report shows that fragility fractures due to osteoporosis are predicted to more than double...

2012-04-03 02:27:12

OR AKIVA, Israel, April 3, 2012 /PRNewswire/ -- Expanding Orthopedics Inc. [http://www.xortho.com ] announced today that the United States Patent and Trademark Office (USPTO) has granted a Patent for its novel expandable device for the treatment of Vertebral Compression Fractures, based on the company's expanding platform technology. Dr. Mark Levy, an orthopedic surgeon and Founder of Expanding Orthopedics, explained that "this new device will be a step forward in the...

2012-03-27 02:27:08

SANTA CLARA, Calif., March 27, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today over 250 patients have been enrolled in the landmark KAST (Kiva System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) clinical trial. KAST is evaluating Benvenue Medical's Kiva VCF Treatment System in the largest randomized study to date versus the current standard of care, balloon kyphoplasty, in vertebral...